1. US Dry Eye OTC Product Comparison.
2. IRI US 2020 Dry Eye Share Competitive Report.
3. 2012. Lemp, Miachael A. Distribution of Aqueous-Deficient and Evaporative Dry Eye in a Clinic-Based Patient Cohort: A Retrospective Study.
4. JJV Data on File 2020. Blink Triple Care Lubricating Eye Drops - Consolidated, Approved Claims List.
5. Laurent TC. Structure of Hyaluronic Acid. In: EA Balazs (Ed.), Chemistry and Molecular Biology of Intracellular Matrix. Academic Press, London. 1970:703-732.
6. Aragona P, Papa V, Micali A, et al. Long Term Treatment with Sodium Hyaluronate-Containing Artificial Tears Reduces Ocular Surface Damage in Patients with Dry Eye. Br. J. Ophthamol. 2002;86(2):181-184. doi: 10.1136/bjo.86.2.181.
7. Prabhasawat P, Tesavibul N, Kasetsuwan K. Performance Profile of Sodium Hyaluronate in Patients with Lipid Tear Deficiency: Randomised, Double-Blind, Controlled, Exploratory Study. Br. J. Ophthalmol. 2007;91(1):47-50. doi:
8. Zheng X, Goto T, Shiraishi A, et al. In vitro efficacy of ocular surface lubricants against dehydration. Invest. Ophthalmol. Vis. Sci. 2013;32(9):1260-1264. doi: 10.1097/j.ico.0b013e31829cfd44.
9. Maissa C, Guillon M, Simmons P, et al. Effect of castor oil emulsion eyedrops on tear film composition and stability. Contact Lens Anterior Eye. 2010;33(2):76-82. doi: 10.1016/j.clae.2009.10.005.
10. Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. The Ocular Surface. 2017;15(3):276-283.
11. Wasmanski AD and Kislan T. Cross-Over Evaluation of Polyethylene Glycol 400 (PEG-400) 0.4% and 0.25% Artificial Tears in Mild Dry Eye Patients. Invest. Ophthalmol. Vis. Sci. 2010;51(13):6263.
12. Montani G. Intrasubject Tear Osmolarity Changes with Two Different Types of Eye Drops. Optom. Vis. Sci. 2013;90(4): 372-377. doi: 10.1097/OPX.0b013e318288bdbe. 10.1136/bjo.2006.097691.
IMPORTANT SAFETY INFORMATION
Blink® Tears, Blink GelTears® and Blink® Triple Care Drops are for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun. Drops may be used as a protectant against further irritation. Patients should stop use and contact their eye care practitioner if they experience eye pain, changes in vision, continued redness, or irritation of the eye, or if the condition worsens or persists for more than 72 hours.
© Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc. 2022 All rights reserved. This site is published by Johnson & Johnson Vision Care, Inc. and Johnson & Johnson Surgical Vision, Inc., which are solely responsible for its content. PP2022CN4054v2.0